Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat

NCT ID: NCT06247462

Last Updated: 2026-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-01

Study Completion Date

2023-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine if ibuprofen prior to exercise in the heat worsens biomarkers of acute kidney injury. Participants were given 600mg of ibuprofen or placebo (corn starch) 12- and 1-hour prior to running for 1-hour in a hot environment (35°C) at moderate intensity. Urine, plasma, and serum samples were collected pre-, post-, and 1hour post-exercise to assess biomarkers of acute kidney injury. This was a double blind, randomized crossover design, so that participants completed the alternate trial (ibuprofen or placebo) at least seven days later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ibuprofen

600 mg of Ibuprofen was ingested 12- and 1-hour prior to exercise.

Group Type EXPERIMENTAL

Ibuprofen 600 mg

Intervention Type DRUG

600 mg of ibuprofen was ingested 12- and 1-hours prior to exercise.

Placebo (Corn Starch)

600 mg of corn starch was ingested 12- and 1-hour prior to exercise.

Group Type PLACEBO_COMPARATOR

Placebo Corn Starch

Intervention Type DRUG

600 mg of corn starch (placebo) was ingested 12- and 1-hours prior to exercise.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen 600 mg

600 mg of ibuprofen was ingested 12- and 1-hours prior to exercise.

Intervention Type DRUG

Placebo Corn Starch

600 mg of corn starch (placebo) was ingested 12- and 1-hours prior to exercise.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physically active (engage in at least 150 minutes of moderate to vigorous intensity exercise per week)
* between the ages of 18 and 45
* Able to run continuously for at least 60 minutes
* Able to speak and read English.

Exclusion Criteria

* Non-English speakers, prisoners, pregnant women, or persons requiring a LAR
* Previous history of heat stroke or heat illness
* Currently experiencing a sunburn or other burn injury
* Have repeated exposure to heat, such as hot baths, sauna, or travel to a hot environment
* Has resided in a hot climate within 2 months prior to the trial
* Answered "yes" to at least one question on the physical activity readiness questionnaire
* Shows signs or symptoms of or are known to have cardiovascular, renal, metabolic, or pulmonary disease as determined by a health questionnaire
* Are a current smoker
* History of regular gastrointestinal distress
* Known history of stomach ulcers or taking blood thinning medication
* Known allergy to ibuprofen
* Have a resting blood pressure greater than 140 systolic or 90 diastolic
* Do not engage in at least 150 minutes of moderate to vigorous intensity exercise per week.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of New Mexico

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exercise Physiology Lab

Albuquerque, New Mexico, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IBU2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Actual Use Trial of Ibuprofen 400 mg
NCT02294019 COMPLETED PHASE3
Ibuprofen Sodium Tension Headache Study
NCT01362491 COMPLETED PHASE3